Read More 1 minute read Analyst Ratings News Price Target JMP Securities Maintains Market Outperform on Ziff Davis, Lowers Price Target to $100 By Benzinga Newsdesk August 11, 10:21 AM JMP Securities analyst Joe Goodwin maintains Ziff Davis (NASDAQ:ZD) with a Market Outperform and lowers the price target from $110 to $100. ZD
Read More 22 minute read Earnings Markets News Pre-Market Outlook Earnings Scheduled For August 9, 2022 By Benzinga Insights August 9, 5:02 AM Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. AAIC